Apple’s App Store war doesn’t end with Epic - Yahoo Finance

company in history to see its market value top $2 trillion, is facing a sustained backlash from app developers both large and small who say its App Store policies are unfair, and in some circumstances, violate antitrust laws.

And perhaps no company is going after Apple with as much gusto as video game publisher and “Fortnite” developer Epic Games, which has filed a lawsuit against Apple claiming its App Store operates as an illegal monopoly. ?

And if Apple loses, it could have a direct impact on the company’s Services business, which pulled in $46 billion last year.

Using that system also requires developers to pay Apple a 30% cut of the total sale price of each purchase customers make.

Apple, meanwhile, has said it won’t budge for one company, and that its App Store guidelines are in place to protect Apple users.

Apple also argues that Epic benefits from the help the company offers in giving it access to the App Store and its audience.

Even if Apple gets through the Epic fight without issue, it isn’t the only company lining up to take on the Silicon Valley behemoth.

And last year, Spotify, which has taken the same approach as Netflix, filed an antitrust complaint against Apple with the European Commission, the European Union’s competition watchdog.

The Supreme Court even struck a blow against Apple last year when it ruled that iPhone owners could sue the company over its 30% App Store fees, opening the firm up to potential class action suits. .

Palantir: How the stock is trading on its first day.

Trump saw his odds fall 4.4% to 38.4%.What About The Stock Market.

A win by Biden could boost China stocks, ETFs and technology companies with large international exposure.The iShares MSCI China ETF (NASDAQ: MCHI) is an ETF to watch, while Tencent (OTC: TCEHY) is a stock that has been hurt by U.S.-China relations.The Technology Select Sector SPDR ETF (NYSE: XLK) could gain on less regulation and tariffs put on China.Other sectors that are expected to win from a Biden presidency are renewable energy and infrastructure.The Global US infrastructure Development ETF (BATS: PAVE) is an infrastructure fund to watch with a Biden win.Biden said Tuesday he doesn't support the Green New Deal proposed by democrats, but has his own Biden Plan that will focus on renewable energy.

He has also proposed raising the capital gains tax, which could hurt the overall market, but would need a Democratic sweep across Congress as well.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Stock Wars: Activision Blizzard Vs.

The stock market is on pace for its worst month since March, though the quarter has been great.

He predicted the mortgage crisis, oil’s fall from $100 to $40, and the March stock market bottom.

By providing a steady income stream, no matter what the market conditions, a reliable dividend stock provides a pad for your investment portfolio when the share stop appreciating.With this in mind, we’ve used the TipRanks database to pull up three dividend stocks yielding 8% or more.

Each of these stocks has a Strong Buy rating, and considerable upside potential.Solar Senior Capital (SUNS)The first stock is Solar Senior Capital, an investment management company focused on an externally managed non-diversified portfolio.

The company has paid out the dividend reliably, no matter the market conditions, since 2011.Covering this stock for Ladenburg, analyst Mickey Schleien rates SUNS a Buy, along with a $15 price target.

The stock’s $12.68 trading price and $15.67 average price target give a one-year upside potential of 24%.

The company has an average price target of $9, suggesting a 12.5% upside from the $8.01 trading price.

(See BBDC stock analysis on TipRanks)TriplePoint Venture Growth (TPVG)The last stock on our list is another management investment company.

The high yield, combined with the reliable payment history, make this dividend valuable, especially in a time of near-zero interest rate policy.Christopher York, 4-star analyst with JMP Securities, believes that the recent second quarter results justify an Outperform (i.e. Buy) rating on TPVG, and his $13 price target implies an upside of 16%.

Meanwhile, their average price target of $13.30 suggests a 19% upside from current levels.

(See TriplePoint’s stock analysis at TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts.

This is borne out by a look at three major components of the index, members of tech’s ‘FAANG’ club.The FAANG stocks are Facebook, Amazon, Apple, Netflix, and Google (Alphabet).

This target implies room for 24% share appreciation in the next year.

The shares are priced at $261.90 and have an average price target of $295.82, suggesting a 13% upside from current levels.

(See FB stock analysis on TipRanks)Amazon.com (AMZN)Next up, Amazon, is the market’s second largest publicly traded company, with a market cap of $1.59 trillion and a famously high share price exceeding $3,000.

The share price comes in at $3,149, and the average price target of $3,732 implies an 18.5% one-year upside potential.

(See AMZN stock analysis on TipRanks)Apple, Inc.

Two years ago, in summer 2018, Apple was the first company to ever exceed $1 trillion in market cap, and earlier this year, Apple broke above $2 trillion.

The company is currently valued at $1.98 trillion.A big advantage for Apple, as the corona crisis took hold, was that the company had entered 2020 on the heels of record-breaking fourth quarter results.

While the $2 trn market cap valuation in itself is a significant milestone, that AAPL shares crossed it in a year with significant COVID-19 disruption testifies to the recurring nature of not only its Services, but also its Products, such that investors are now willing to pay a Services-like premium on the entire earnings stream and a modest premium on account of expectations for further revenue/earnings upside.

(To watch Chatterjee’s track record, click here)All in all, Apple holds a Moderate Buy rating from the analyst consensus, with 35 reviews breaking down to 24 Buys, 8 Holds, and 3 Sells.

The shares are selling for $115.81 and have an average price target of $122.04.

(See Apple stock analysis at TipRanks)To find good ideas for tech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts.

EV stocks have soared 500%, 800%, even 1,000% this year.

Investment firm Goldman Sachs just gave its three-month stock forecast a boost, lifting it from Neutral to Overweight, with it also projecting “high single-digital returns” for global stocks over the next year.What’s behind this updated approach.

equities more, but in the medium term a large weight in structural growth stocks is likely to support the S&P 500,” Mueller-Glissmann noted.As for the “most important catalyst” that could spur growth optimism in the next year, the strategist points to additional clarity on when and how a COVID-19 vaccine will be available.Turning Mueller-Glissmann's outlook into concrete recommendations, Goldman Sachs’ analysts are pounding the table on three stocks that look especially compelling.

While shares have stumbled in 2020, Goldman Sachs thinks the weakness presents a buying opportunity.Representing the firm, analyst Noah Poponak points out that RTX is “too high quality and well positioned of a company to trade at an 11% free cash flow yield on the fully aerospace-recovered and fully synergized 2023E free cash.”The analyst’s bullish outlook is largely driven by the company’s aerospace aftermarket (the secondary market that deals with the installation of equipment, spare parts, accessories and components after the sale of the aircraft by the original equipment manufacturer) business, which Poponak argues is “the best sub-market within Aerospace over the long-term.” This segment makes up roughly 45% of RTX’s aerospace revenue.Even though COVID-19 flight disruptions have weighed on this part of the business, Poponak points out total aircraft in service is down only 25% year-over-year, and flights have dipped less than 50%.

To this end, he keeps a Buy rating and $86 price target on the stock.

With an average price target of $78.63, the upside potential comes in at 36.5%.

(See RTX stock analysis on TipRanks)Boeing (BA)Moving on to another player in the aerospace space, Boeing has also struggled on account of the COVID-19 pandemic, with it failing to match the pace of the broader market.

The company is working towards recertification and return to service, with Poponak expecting both to come before year-end.Taking all of the above into consideration, Poponak maintains a Buy rating and $225 price target.

At $192.40, the average price target implies 16% upside potential.

(See Boeing stock analysis on TipRanks)Immatics (IMTX)Combining the discovery of true targets for cancer immunotherapies (therapies that utilize the power of the immune system) with the development of the right T cell receptors, Immatics hopes to ultimately enable a robust and specific T cell response against these targets.

The company is advancing two technologies: ACTengine, designed for personalized TCR-based cell therapies, and TCER, which targets TCR-based bispecific antibodies.ACTengine is the more advanced technology, with its four assets IMA201, a genetically engineered T cell product candidate that targets melanoma-associated antigen 4 or 8, IMA202, which targets melanoma-associated antigen 1, IMA203, which targets preferentially expressed antigen in melanoma (PRAME) and IMA204 that targets COL6A3 (found in a tumor’s stroma and is highly prevalent in the tumor microenvironment/TME in a broad range of cancers) expected to enter the clinic soon.Using the TCER platform, IMTX is developing IMA401 and IMA402, or “off-the-shelf” biologics consisting of a portion of the TCR which directly recognizes cancer cells and a T cell recruiter domain which recruits and activates the patient’s T cells.Speaking to the market opportunity, Suvannavejh mentioned, “Cancer immunotherapies have made great strides over the past decade, and in particular, advances seen with CAR-T have paved the way for cell therapy-based approaches...

Given the $19 average price target, shares could soar 93% in the next year.

(See Immatics stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts.

Investors cheered, rewarding him with a 3,600% stock-surge since he joined the company a year ago.Trillium is the No.

1 stock on Canada’s S&P/TSX Composite Index this year, skyrocketing past tech behemoth Shopify Inc.

Wall Street has an average 12-month share price target of $17.58, implying gains of about 30% over the coming year, data compiled by Bloomberg show.

For Skvarka, who celebrated the anniversary of his first year last weekend, the decision to restructure the company and focus on a newer cancer technology has transformed the drugmaker into a firm with a market cap of about $1.3 billion.

Near term, we continue to expect record 3Q/4Q deliveries and margin, boosted by the newly launched EC6 SUV coupe (deliveries began on Friday), 100 kWh battery pack option, and BaaS roll-out.”To this end, Yu reiterated a Buy rating on NIO shares along with a $24 price target.

However, the analysts expect shares to trend downwards by 19% as indicated by the $17.14 average price target.

(See Nio stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts.

Leon Cooperman, the 77-year-old billionaire chief executive of hedge fund Omega Advisers, has a lot of thoughts on the stock market.

Micron expects the impact of halted shipments to the Chinese telecom giant to be offset by the close of F2Q21.Despite Wall Street’s lukewarm reception, Rosenblatt analyst Hans Mosemann calls the November quarter guide “mixed but better than feared.”While the short-term outlook is weakened by reduced enterprise demand, lower IT spending and certain customers’ higher inventories, the 5-star analyst remains bullish on Micron’s long-term prospects.Mosesmann commented, “Looking into Micron's end markets, the company has started to see certain end market recoveries, including Smartphones, Automotive, and Consumer

We think the setup for Micron for investors looking into 2021/22 is for a memory cycle driven by traditional S/D dynamics, Micron’s new DRAM 1Z and 1- alpha ramps, and 2nd generation RG NAND ramps.”Overall, Mosesmann reiterates a Buy rating on MU shares along with a $100 price target

Based on 14 Buys, 4 Holds and 1 Sell, the stock has a Moderate Buy consensus rating

There’s possible upside of 29%, should the $60.78 average price target be met over the next 12 months

(See Micron stock analysis on TipRanks)To find good ideas for tech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analyst